Ash Stevens Overview
- Founded
-
1962
- Status
-
Acquired/Merged
- Employees
-
51
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Ash Stevens General Information
Description
Provider of pharmaceutical contract manufacturing services. The company offers process development, route optimization, API (active pharmaceutical ingredient) manufacturing, high Potency APIs, analytical support, regulatory compliance, and project management services.
Contact Information
Website
www.ashstevens.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 18655 Krause Street
- Riverview, MI 48193
- United States
Ash Stevens Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ash Stevens Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of pharmaceutical contract manufacturing services. The company offers process development, route optimization,
Pharmaceuticals
Riverview, MI
51
As of 2016
000
0000-00-00
000000&0
000000
erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
000000000000000
Ravensburg, Germany
0000
As of 0000
000000000 00
000000
t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
000000000000000
Montreal, Canada
000
As of 0000
Add Comparison
Ash Stevens Competitors (36)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | 0000 | 000000000 00 | ||
| 000000 000000 0000 | Corporation | Montreal, Canada | 000 | |||
| 0000000000 000000 | Corporation | Ennigerloh, Germany | ||||
| 00000000 | Formerly PE-Backed | Lodi, Italy | 000 | 00000 | 000000&0 | 00000 |
| 000000000 000-0000 | Corporation | San Diego, CA |
Ash Stevens Patents
Ash Stevens Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-642611-B1 | Improved process | Inactive | 08-Jul-1992 | 000000000 | |
| CA-2091732-A1 | A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine | Active | 08-Jul-1992 | 000000000 | |
| CA-2091732-C | A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine | Inactive | 08-Jul-1992 | 000000000 | |
| DE-69301134-T2 | Process for the preparation of 2-fluoro-9- (2,3,5-tri-o-benzyl-beta-arabinofuranosyl) adenine | Inactive | 08-Jul-1992 | 000000000 | |
| DE-69301134-D1 | Process for the preparation of 2-fluoro-9- (2,3,5-tri-o-benzyl-beta-arabinofuranosyl) adenine | Inactive | 08-Jul-1992 | C07H19/16 |
Ash Stevens Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
